Outcomes with single agent LIPO-DOX in platinum-resistant ovarian and fallopian tube cancers and primary peritoneal adenocarcinoma - Chiang Mai University Hospital experience

• Main Authors: Suprasert P., Manopunya M., Cheewakriangkrai C.
• 格式: Article
• 語言: English
• 出版: Asian Pacific Organization for Cancer Prevention 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-84896820972&partnerID=40&md5=09179a068b0dbcb9af6131afa102ac4c; http://www.ncbi.nlm.nih.gov/pubmed/24606432; http://cmuir.cmu.ac.th/handle/6653943832/1702

Background: Single pegylated liposomal doxorubicin (PLD) is commonly used as a salvage treatment in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma (PPA) with a satisfactory outcome. However, the data for second generation PLD administered in this setti...